New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Altamira Therapeutics Ltd.
CYTO
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

2M

Biotechnology

0.60USD
Shape-0.02 ( -2.80%)
favorite-chart

Relative Strenght

10
favorite-chart

Volume Buzz

-86%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

97%

Quote Panel

Shape
Updated October 12, 2024
1W -3.21 % 1M -28.56 % 3M -55.55 % 1Y -87.39 %

Key Metrics

Shape
  • Market Cap

    2.27M


  • Shares Outstanding

    3.78M


  • Share in Float

    3.76M


  • Dividende

    0


  • Earning Date

    No Data


  • Price Target

    0.6001


  • Average Volume

    446507


  • Beta

    2.414


  • Range

    0.585-17.2


  • Industry

    Biotechnology


  • Website

    https://altamiratherapeutics.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.00x

P/S Ratio

0.04x

P/B Ratio

0.0

Debt/Equity

0.0%

Net Margin

$1.8

EPS

How CYTO compares to sector?

P/E Ratio

Relative Strength

Shape

CYTO

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape
0

$0.98

Shape56%

2025-EPS

0

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.21

arrow
arrow

N/A

-4195.16
vs NA

Q4.21

arrow
arrow

+5234%

8.6K
vs -168.42

Q1.22

arrow
arrow

N/A

-114.84
vs -115.16

Q2.22

arrow
arrow

N/A

-110.98
vs -117.42

Q3.22

arrow
arrow

N/A

-3.13
vs -4195.16

Q4.22

arrow
arrow

N/A

NA
vs 8.6K

Q1.23

arrow
arrow

N/A

-14.09
vs -114.84

Q2.23

arrow
arrow

+100%

NA
vs -110.98

Q2.24

arrow
arrow

N/A

-2.22
vs NA

Q3.24

arrow
arrow

N/A

-541.65
vs NA

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.21

arrow
arrow

NA

NA  vs NA

Q4.21

arrow
arrow

-100%

NA  vs 237K

Q1.22

arrow
arrow

NA

145.4K  vs NA

Q2.22

arrow
arrow

NA

145.4K  vs NA

Q3.22

arrow
arrow

NA

-458691.00  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

-64%

52.7K  vs 145.4K

Q2.23

arrow
arrow

-64%

52.7K  vs 145.4K

Q2.24

arrow
arrow

-41%

31.2K  vs 52.7K

Q3.24

arrow
arrow

NA

27.4K  vs NA

Return on EquityShape

status-upQoQ

Q1.22

arrow
arrow

-61%

-0.61
vs 0.41

Q2.22

arrow
arrow

-54%

-0.54
vs -0.61

Q3.22

arrow
arrow

+116%

1.16
vs -0.54

Q4.22

arrow
arrow

+10%

0.1
vs 1.16

Q1.23

arrow
arrow

+149%

1.49
vs 0.1

Q2.23

arrow
arrow

+149%

1.49
vs 1.49

Q3.23

arrow
arrow

NA

NA
vs 1.49

Q4.23

arrow
arrow

NA

NA
vs NA

Institutionnal OwnershipShape

status-upQoQ

Q3.21

arrow
arrow

16

16
vs NA

NA

Q4.21

arrow
arrow

18

18
vs 16

13%

Q1.22

arrow
arrow

15

15
vs 18

-17%

Q2.22

arrow
arrow

11

11
vs 15

-27%

Q3.22

arrow
arrow

11

11
vs 11

NA

Earnings Growth

Latest News